Table 2. Rates of Baseline Severity, Outcomes, Clinical Complications, and Interventions Received After COVID-19 Diagnosis.
| Variable | All patients (N = 3506) | Black patients | White patients | |||
|---|---|---|---|---|---|---|
| No.a | No. (%) | No.a | No. (%) | No.a | No. (%) | |
| Baseline severityb | ||||||
| Mild (no hospitalization indicated) | 3480 | 1775 (51) | 1062 | 461 (43) | 2402 | 1314 (55) |
| Moderate (hospitalization indicated) | 3480 | 1236 (36) | 1062 | 437 (41) | 2402 | 826 (34) |
| Severe (ICU admission indicated) | 3480 | 426 (12) | 1062 | 164 (15) | 2402 | 262 (11) |
| Outcomes | ||||||
| All-cause mortality | ||||||
| Totalc | 3485 | 618 (18) | 1060 | 206 (19) | 2425 | 412 (17) |
| 30-dd | 3506 | 507 (14) | 1068 | 181 (17) | 2438 | 326 (13) |
| Received mechanical ventilationc | 3495 | 412 (12) | 1065 | 179 (17) | 2430 | 233 (10) |
| Admitted to an ICUc | 3444 | 622 (18) | 1057 | 238 (23) | 2387 | 384 (16) |
| Admitted to the hospitalc | 3505 | 2026 (58) | 1068 | 696 (65) | 2437 | 1330 (55) |
| Clinical complications | ||||||
| Any cardiovascular complicatione | 3379 | 793 (23) | 1028 | 267 (26) | 2351 | 526 (22) |
| Any pulmonary complicatione | 3441 | 1289 (37) | 1051 | 442 (42) | 2390 | 847 (35) |
| Any gastrointestinal complicatione | 3337 | 129 (4) | 1016 | 52 (5) | 2321 | 77 (3) |
| Acute kidney injury | 3376 | 624 (18) | 1029 | 275 (27) | 2347 | 349 (15) |
| Multisystem organ failure | 3420 | 216 (6) | 1040 | 101 (10) | 2380 | 115 (5) |
| Coinfection | 3270 | 353 (11) | 1004 | 183 (18) | 2290 | 450 (20) |
| Sepsis | 3425 | 448 (13) | 1042 | 170 (16) | 2383 | 278 (12) |
| Any bleeding | 3419 | 122 (4) | 1041 | 51 (5) | 2378 | 71 (3) |
| Disseminated intravascular coagulation | 3414 | 13 (<1) | 1039 | 7 (1) | 2375 | 6 (<1) |
| Interventions | ||||||
| Supplemental oxygen | 3440 | 1511 (44) | 1054 | 501 (48) | 2386 | 1010 (42) |
| Transfusion | 3287 | 252 (8) | 1001 | 102 (10) | 2286 | 150 (7) |
| Remdesivir | 3326 | 303 (9) | 1020 | 61 (6) | 2306 | 242 (10) |
| Hydroxychloroquine | 3323 | 593 (18) | 1020 | 245 (24) | 2303 | 348 (15) |
| Corticosteroids | 3322 | 518 (16) | 1020 | 175 (17) | 2302 | 343 (15) |
| Other anti-COVID-19 treatments | 3324 | 827 (25) | 1020 | 278 (27) | 2304 | 549 (24) |
Abbreviation: ICU, intensive care unit.
a
Refers to number of patients with nonmissing data.
b
Mild denotes no hospitalization indicated, moderate denotes hospitalization indicated whether or not it occurred, and severe denotes ICU admission indicated, whether or not it occurred.
c
Included in primary ordinal COVID-19 severity outcome.
d
Refers to secondary outcome.
e
A full description of these complications is provided in eTable 4 in Supplement 1 and do not include “other.”